Microbot Medical
MBOT
18 hedge funds and large institutions have $787K invested in Microbot Medical in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 11 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0.48% more ownership
Funds ownership: 0% → 0.48% (+0.48%)
25% less funds holding
Funds holding: 24 → 18 (-6)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
60% less capital invested
Capital invested by funds: $1.95M → $787K (-$1.16M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$130K |
| 2 |
Millennium Management
New York
|
+$129K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$93.5K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$72.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$62.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$362K |
| 2 |
Renaissance Technologies
New York
|
-$279K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$187K |
| 4 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
-$93K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$34K |
MBOT Hedge Fund Activity: Q4 2016 in Review
18 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2016, worth a combined $787K — down 60% from $1.95M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of MBOT and 5 opened new positions — a net loss of 6 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Geode Capital Management, adding an estimated $130K. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $362K sold.
- 18 institutional investors held Microbot Medical (MBOT) as of Q4 2016, down from 24 in Q3 2016.
- Funds reported $787K of Microbot Medical stock for Q4 2016, down 60% quarter-over-quarter.
- 5 funds opened new Microbot Medical positions in Q4 2016 and 11 closed out, a net change of -6 holders.
- The largest Microbot Medical buyer in Q4 2016 was Geode Capital Management, an estimated $130K added.
- The largest Microbot Medical seller in Q4 2016 was D.E. Shaw & Co, an estimated $362K sold.
Based on aggregated 13F filings for Q4 2016.